Bleomycin enhanced the production of the mature form of IL-33 in lung tissue, while deletion of the IL-33 receptor (IL-1 receptor-like 1; ST2) attenuated the bleomycin-induced lung inflammation and fibrosis [15]. The gene discussed is IL33; the disease is inflammation.